Coherus BioSciences

Coherus builds biosimilars - molecular mimics of expensive biologics that fool the immune system into equivalent responses. Like Batesian mimicry where harmless species copy warning colors of toxic ones, biosimilars replicate the functional shape of proteins at far lower cost. The FDA accepts the deception if clinical endpoints match.